Holdings of SR One Capital Management, LP
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 11 in 1 countries
- Top ten
- 99.6 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ARCELLX INC | 2,346,630 | 269.4M $ | |
| 2 | VERADERMICS INC | 2,401,868 | 151.7M $ | |
| 3 | ZENAS BIOPHARMA INC | 5,037,854 | 98.5M $ | |
| 4 | Design Therapeutics Inc | 6,526,476 | 69.4M $ | |
| 5 | ORIC Pharmaceuticals Inc | 4,514,929 | 58.5M $ | |
| 6 | ALUMIS INC | 1,959,896 | 43.2M $ | |
| 7 | Mineralys Therapeutics Inc | 1,563,966 | 42.4M $ | |
| 8 | ARS Pharmaceuticals Inc | 4,012,903 | 32.2M $ | |
| 9 | ORUKA THERAPEUTICS INC | 430,330 | 21.1M $ | |
| 10 | Nkarta Inc | 3,333,333 | 7M $ | |
| 11 | Ultragenyx Pharmaceutical Inc | 137,753 | 2.9M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 11 | 796.3M $ | 100.00 % |
Cite this page
Titelia. "Holdings of SR One Capital Management, LP". https://titelia.com/en/funds/US13F1910264